KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Capital Employed (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Capital Employed over the past 15 years, most recently at 0.02% for Q4 2025.

  • Quarterly Return on Capital Employed fell 8.0% to 0.02% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.02% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.04% for FY2025, 11.0% down from the prior year.
  • Return on Capital Employed was 0.02% for Q4 2025 at Jazz Pharmaceuticals, up from 0.02% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 0.12% in Q1 2021 and troughed at 0.02% in Q3 2025.
  • The 5-year median for Return on Capital Employed is 0.02% (2022), against an average of 0.03%.
  • Biggest five-year swings in Return on Capital Employed: rose 8bps in 2021 and later dropped -12bps in 2022.
  • Tracing JAZZ's Return on Capital Employed over 5 years: stood at 0.01% in 2021, then crashed by -146bps to 0.01% in 2022, then skyrocketed by 975bps to 0.06% in 2023, then rose by 9bps to 0.06% in 2024, then tumbled by -131bps to 0.02% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.02%, 0.02%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.